12:00 AM
Nov 12, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

PAT-SM6: Phase I/IIa started

Patrys began an open-label, dose-escalation, German Phase I/IIa trial to evaluate multiple doses of PAT-SM6 in about 12 patients with relapsed and refractory MM....

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >